(Q57226016)

English

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

article published in 2011

In more languages

Statements

scholarly article

0 references

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation (English)

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Ji-Won Kim

1

0 references

Byung-Su Kim

2

0 references

Soo-Mee Bang

3

0 references

Inho Kim

4

0 references

Dong Hwan Kim

5

0 references

Won Seog Kim

6

0 references

Deok-Hwan Yang

7

0 references

Je-Jung Lee

8

0 references

Je-Hwan Lee

9

0 references

Jin Seok Kim

10

0 references

Sang-Kyun Sohn

11

0 references

Ho-Young Yhim

12

0 references

Jae-Yong Kwak

13

0 references

Sung-Soo Yoon

14

0 references

Jong Seok Lee

15

0 references

Seonyang Park

16

0 references

Byoung Kook Kim

17

0 references

language of work or name

0 references

publication date

December 2011

0 references

Annals of Hematology

0 references

90

0 references

12

0 references

1409-18

0 references

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

The role of allogeneic transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Allogeneic transplantation in lymphoma: current status

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1227-Y

21 January 2018

Identifiers

10.1007/S00277-011-1227-Y

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57226016&oldid=1977611946"